# Hinge Health Surpasses Break-Even with AI-Driven Growth

> Hinge Health's Q2 2026 earnings show profitability and 53% revenue growth, fueled by AI care models and strong client retention.
- Title: Hinge Health Surpasses Break-Even with AI-Driven Growth
- Summary: Hinge Health's Q2 2026 earnings show profitability and 53% revenue growth, fueled by AI care models and strong client retention. Hinge Health achieved…
- Keywords: hinge health, ai care, migraine care, musculoskeletal care, hng, nyse, cylinder health, series e, share repurchase, operating cash flow, Hinge, Health
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/exceptional-earnings-and-ai-immunity-fuel-hinge-healths-hnge-performance
- Author: Newsdesk
- Published: 2026-09-23T20:22:37+00:00
- Read time: 1 min
- Topics: hinge health, ai care, migraine care, musculoskeletal care, hng, nyse, cylinder health, series e, share repurchase, operating cash flow
## Profitability Shift
Hinge Health reported $43.7 million net income in Q2 2026, reversing a $575.7 million loss from Q2 2025.
## Revenue Surge
Q2 2026 revenue reached $212.8 million, a 53% year-over-year increase from $139.1 million in Q2 2025.
## AI Care Model
The company's AI-powered care model combines algorithmic engagement with expert clinicians and wearable devices.
## Deferred Revenue
Hinge Health holds $416.5 million in deferred revenue, all noncancellable performance obligations.
## Liquidity Boost
The company has $474.1 million in liquid assets, including $286.2 million cash and $103.2 million in short-term securities.
## Share Repurchase
Hinge Health increased share repurchase authorization to $496.5 million, with $300 million allocated for Q3 2026.
## Cylinder Health
The acquisition of Cylinder Health expands Hinge Health's addressable market into gastrointestinal care.
## Key takeaway

Hinge Health achieved profitability in Q2 2026 with $43.7 million net income after reversing a $575.7 million loss in Q2 2025.